Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

pRESET for Occlusive Stroke Treatment

NCT03994822 is registered in ClinicalTrials.gov with phenox Inc. as lead sponsor.

NCT NCT03994822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03994822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
pRESET for Occlusive Stroke Treatment
Lead sponsor
phenox Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 4, 2019
Completion date
May 12, 2022
Enrollment
340 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

brain diseases, cardiovascular diseases, central nervous system diseases, cerebrovascular disorders, ischemia, nervous system diseases, pathologic processes, stroke, acute, stroke, ischemic, vascular diseases